Amb motiu del tancament d'estiu, la validació de documents es reprendrà a partir del 28 d'agost de 2026. Disculpeu les molèsties.
Con motivo del cierre de verano, la validación de documentos se reanudará a partir del 28 de agosto de 2026. Disculpad las molestias
Due to the summer closure, document validation will resume starting August 28, 2026. We apologize for any inconvenience.

Document type

Article

Version

Published version

Publication date

Publication license

cc-by (c) Krzyzewska, I.M. et al., 2019
Please use this identifier to cite or link to this item: https://hdl.handle.net/2445/157659

A genome-wide DNA methylation signature for SETD1B-related syndrome

Journal Title

Director/Tutor

Journal ISSN

Volume Title

Abstract

SETD1B is a component of a histone methyltransferase complex that specifically methylates Lys-4 of histone H3 (H3K4) and is responsible for the epigenetic control of chromatin structure and gene expression. De novo microdeletions encompassing this gene as well as de novo missense mutations were previously linked to syndromic intellectual disability (ID). Here, we identify a specific hypermethylation signature associated with loss of function mutations in the SETD1B gene which may be used as an epigenetic marker supporting the diagnosis of syndromic SETD1B-related diseases. We demonstrate the clinical utility of this unique epi-signature by reclassifying previously identified SETD1B VUS (variant of uncertain significance) in two patients.

Subject (English)

Citation

Citation

KRZYZEWSKA, I. M., et al. A genome-wide DNA methylation signature for SETD1B-related syndrome. Clinical Epigenetics. 2019. Vol. 11, num. 156. ISSN 1868-7075. [consulted: 15 of August of 2026]. Available at: https://hdl.handle.net/2445/157659

Export metadata

JSON - METS

Share record